|
Volumn 10, Issue 3, 2012, Pages 256-261
|
Week 96 outcomes of patients with less treatment experience versus more treatment experience receiving etravirine in the DUET trials
|
Author keywords
Antiretroviral; Clinical trials; Efficacy; Etravirine; HIV; Treatment experienced
|
Indexed keywords
DARUNAVIR PLUS RITONAVIR;
ENFUVIRTIDE;
ETRAVIRINE;
PLACEBO;
ADVERSE OUTCOME;
ARTICLE;
CD4+ T LYMPHOCYTE;
CONTROLLED STUDY;
DEMOGRAPHY;
DISEASE ASSOCIATION;
DISEASE DURATION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
MACULOPAPULAR RASH;
MAJOR CLINICAL STUDY;
POST HOC ANALYSIS;
RANDOMIZED CONTROLLED TRIAL;
RASH;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
VIROLOGIC RESPONSE;
VIRUS LOAD;
|
EID: 84861168884
PISSN: 1570162X
EISSN: 18734251
Source Type: Journal
DOI: 10.2174/157016212800618110 Document Type: Article |
Times cited : (3)
|
References (5)
|